Association between the triglyceride-glucose index and albuminuria in hypertensive individuals

References

• Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–6. doi:10.1016/j.jacc.2020.11.010.
   PubMed Web of Science ®Google Scholar
• Shengshou H. Report on cardiovascular health and diseases burden in China: an updated summary of 2020. Chin Circ J. 2021, 36 (6), 521–45.
   Google Scholar
• Ruilope LM. Current challenges in the clinical management of hypertension. Nat Rev Cardiol. 2011;9(5):267–75. doi:10.1038/nrcardio.2011.157.
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104. doi:10.1093/eurheartj/ehy339.
   PubMed Web of Science ®Google Scholar
• Agrawal B, Berger A, Wolf K, Luft FC. Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension. J Hypertens. 1996;14(2):223–28. doi:10.1097/00004872-199602000-00011.
   PubMed Web of Science ®Google Scholar
• Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073–81. doi:10.1016/s0140-6736(10)60674-5.
   PubMed Web of Science ®Google Scholar
• Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615–25. doi:10.2337/diabetes.54.6.1615.
   PubMed Web of Science ®Google Scholar
• Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, Martínez-Abundis E, Ramos-Zavala MG, Hernández-González SO, Jacques-Camarena O, Rodríguez-Morán M. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347–51. doi:10.1210/jc.2010-0288.
   PubMed Web of Science ®Google Scholar
• Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304. doi:10.1089/met.2008.0034.
   PubMedGoogle Scholar
• Du T, Yuan G, Zhang M, Zhou X, Sun X, Yu X. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance. Cardiovasc Diabetol. 2014;13:146. doi:10.1186/s12933-014-0146-3.
   PubMed Web of Science ®Google Scholar
• Sánchez-Íñigo L, Navarro-González D, Fernández-Montero A, Pastrana-Delgado J, Martínez JA. The TyG index may predict the development of cardiovascular events. Eur J Clin Invest. 2016;46(2):189–97. doi:10.1111/eci.12583.
   PubMed Web of Science ®Google Scholar
• Ding X, Wang X, Wu J, Zhang M, Cui M. Triglyceride-glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol. 2021;20(1):76. doi:10.1186/s12933-021-01268-9.
   PubMed Web of Science ®Google Scholar
• Hong S, Han K, Park CY. The triglyceride glucose index is a simple and low-cost marker associated with atherosclerotic cardiovascular disease: a population-based study. BMC Med. 2020;18(1):361. doi:10.1186/s12916-020-01824-2.
   PubMed Web of Science ®Google Scholar
• Miao M, Zhou G, Bao A, Sun Y, Du H, Song L, Cao Y, You S, Zhong C. Triglyceride-glucose index and common carotid artery intima-media thickness in patients with ischemic stroke. Cardiovasc Diabetol. 2022;21(1):43. doi:10.1186/s12933-022-01472-1.
   PubMed Web of Science ®Google Scholar
• Li M, Zhan A, Huang X, Hu L, Zhou W, Wang T, Zhu L, Bao H, Cheng X. Positive association between triglyceride glucose index and arterial stiffness in hypertensive patients: the China H-type hypertension registry study. Cardiovasc Diabetol. 2020;19(1):139. doi:10.1186/s12933-020-01124-2.
   PubMed Web of Science ®Google Scholar
• Zhao S, Yu S, Chi C, Fan X, Tang J, Ji H, Teliewubai J, Zhang Y, Xu Y. Association between macro- and microvascular damage and the triglyceride glucose index in community-dwelling elderly individuals: the Northern Shanghai Study. Cardiovasc Diabetol. 2019;18(1):95. doi:10.1186/s12933-019-0898-x.
   PubMed Web of Science ®Google Scholar
• Sehestedt T, Jeppesen J, Hansen TW, Wachtell K, Ibsen H, Torp-Pedersen C, Hildebrandt P, Olsen MH. Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Eur Heart J. 2010;31(7):883–91. doi:10.1093/eurheartj/ehp546.
   PubMed Web of Science ®Google Scholar
• Savarese G, Dei Cas A, Rosano G, D’Amore C, Musella F, Mosca S, Reiner MF, Marchioli R, Trimarco B, Perrone-Filardi P. Reduction of albumin urinary excretion is associated with reduced cardiovascular events in hypertensive and/or diabetic patients. A meta-regression analysis of 32 randomized trials. Int J Cardiol. 2014;172(2):403–10. doi:10.1016/j.ijcard.2014.01.065.
   PubMed Web of Science ®Google Scholar
• Tani Y, Nakayama M, Kanno M, Kimura H, Watanabe K, Tanaka K, Hayashi Y, Asahi K, Iseki K, Watanabe T. The clinical applicability of albuminuria testing in Japanese hypertensive patients: the AVA-E study. Intern Med. 2013;52(4):425–30. doi:10.2169/internalmedicine.52.8854.
   PubMed Web of Science ®Google Scholar
• Chiu H, Tsai HJ, Huang JC, Wu PY, Hsu WH, Lee MY, Chen SC. Associations between triglyceride-glucose index and micro- and macro-angiopathies in type 2 diabetes mellitus. Nutrients. 2020;12(2). doi:10.3390/nu12020328.
   Web of Science ®Google Scholar
• Pranata R, Huang I, Irvan LMA, Vania R. The association between triglyceride-glucose index and the incidence of type 2 diabetes mellitus-a systematic review and dose-response meta-analysis of cohort studies. Endocrine. 2021;74(2):254–62. doi:10.1007/s12020-021-02780-4.
   PubMed Web of Science ®Google Scholar
• Zheng R, Mao Y. Triglyceride and glucose (TyG) index as a predictor of incident hypertension: a 9-year longitudinal population-based study. Lipids Health Dis. 2017;16(1):175. doi:10.1186/s12944-017-0562-y.
   PubMed Web of Science ®Google Scholar
• Khan SH, Sobia F, Niazi NK, Manzoor SM, Fazal N, Ahmad F. Metabolic clustering of risk factors: evaluation of Triglyceride-glucose index (TyG index) for evaluation of insulin resistance. Diabetol Metab Syndr. 2018;10(1):74. doi:10.1186/s13098-018-0376-8.
   PubMedGoogle Scholar
• Zhu B, Wang J, Chen K, Yan W, Wang A, Wang W, Gao Z, Tang X, Yan L, Wan Q, et al. A high triglyceride glucose index is more closely associated with hypertension than lipid or glycemic parameters in elderly individuals: a cross-sectional survey from the reaction study. Cardiovasc Diabetol. 2020;19(1):112. doi:10.1186/s12933-020-01077-6.
   PubMed Web of Science ®Google Scholar
• Bolton CH, Downs LG, Victory JG, Dwight JF, Tomson CR, Mackness MI, Pinkney JH. Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant. 2001;16(6):1189–97. doi:10.1093/ndt/16.6.1189.
   PubMed Web of Science ®Google Scholar